diabetes-symposium - lectures - online

Is diabetes a cardiovascular disease equivalent?
30-Jun-10 , Munich - Orlando, Germany
Diabetes and Cardiovascular Disease: Pathways for prevention – Munich Diabetes Research Institute
10-Apr-10 , Dresden, Germany
Structured SMBG and new therapeutic strategies to improve glycemic control in Type 2 diabetes patients not using insulin
20-Oct-09 , Montreal, Canada
Diabetes and the Heart: State-of-the-art treatment strategies
19-Oct-09 , Montreal, Canada
Wake up to sleep apnoea and diabetes
18-Oct-09 , Montreal, Canada
Diabetes, Prediabetes and CVD – the Need for Early Intervention
18-Oct-09 , Montreal, Canada
The place of saxagliptin as a potential new treatment for patients with type 2 diabetes
29-Sep-09 , Vienna, Austria
STRUCTURED SMBG: A practical and efficient strategy to improve glycaemic control in patients with type 2 diabetes not using insulin
29-Sep-09 , Vienna, Austria
Linking sleep apnoea, cardiology and diabetes: what you don't know may surprise you!
31-Aug-09 , Barcelona, Spain
What more can we achieve beyond mono and combination therapy for hypertension management?
29-Aug-09 , Barcelona, Spain
Diabetes and the Heart: Guidelines for the Clinical Practice – Epidemiology, Classification and Pathophysiology
30-Jan-09 , Munich, Germany
Diabetes and the Heart: Guidelines for the Clinical Practice – Risk Screening and Diagnostic Approaches
30-Jan-09 , Munich, Germany
Improving Glucose Control: The Role of Sitagliptin in Early Combination Therapy
07-Sep-08 , Rome, Italy
Translating the Science to Improve Patient Outcomes
07-Sep-08 , Rome, Italy
Preventing diabetes and cardiovascular disease - entering a new era with acarbose
01-Jun-08 , Helsinki, Finland
Our Children with Diabetes
27-Sep-07 , On the occasion of the Annual Meeting of ISPAD, Berlin, Germany
Aiming For Goal - The New Player In The Management Of Type 2 Diabetes
18-Sep-07 , On the occasion of the Annual Meeting of the EASD, Amsterdam, Netherlands
Optimal Glycaemic Control Under Scrutiny: What, Why and How?
17-Oct-07 , On the occasion of the Annual Meeting of the EASD, Amsterdam, Netherlands
Integrated Approaches to Diabetes Management
17-Sep-07 , On the occasion of the Annual Meeting of the EASD, Amsterdam, Netherlands
Achieving Glycemic Control Without Therapeutic Compromise: The Role Of Sigtagliptin - A Novel Incretin Enhancer For Type 2 Diabetes
17-Sep-07 , On the occasion of the Annual Meeting of the EASD, Amsterdam, Netherlands
Transfering Diabetes And CVD Prevention Into Daily Practice - Time To Act Now!
17-Sep-07 , On the occasion of the Annual Meeting of the EASD, Amsterdam, Netherlands
Diabetes Self-Management with Novel Decision Support Tools
23-Jun-07 , Chicago, United States
Managing prediabetes – the global need for early intervention
03-Dec-06 , Capetown, South Africa
Entering an exciting era of diabetes and CVD prevention – a new outcome trial with Glucobay®
03-Dec-06 , Capetown, South Africa
The Value of SMBG in Type 2 Diabetes
03-Dec-06 , Capetown, South Africa
New Global IDF Criteria on the Metabolic Syndrome
22-Sep-06 , Munich, Germany
Diabetes Management: From Today´s Standards to Tomorrow´s
13-Sep-06 , On the occasion of the Annual Meeting of the EASD, Copenhagen, Denmark
Diabetes and Obstructive Sleep Apnea – A Dangerous Combination
13-Sep-06 , On the occasion of the Annual Meeting of the EASD, Copenhagen, Denmark
A Decade of Insulin Analogues: An Appraisal of the Science and Clinical Applications
12-Sep-06 , On the occasion of the Annual Meeting of the EASD, Copenhagen, Denmark
Neuropad®: Miro symposium of EASD
13-Sep-05 , On the occasion of the Annual Meeting of the EASD, Athens, Greece
Blockade of the renin–angiotensin system: added value in reducing renal and cardiovascular risk
11-Sep-05 , On the occasion of the Annual Meeting of the EASD, Athens, Greece
A new generation of glucose monitoring – real time continuous systems
11-Sep-05 , On the occasion of the Annual Meeting of the EASD, Athens, Greece
Incretin enhancers restoring pancreatic islet health. Slowing diabetes progression?
11-Sep-05 , On the occasion of the Annual Meeting of the EASD, Athens, Greece
Real–Time Continuous: the Link to the Future of Continuous Monitoring
05-May-05 , Berlin, Germany
Early Intervention in the Type 2 Diabetes Mellitus Continuum: Is It Important? Is It Possible? Is It Practical?
13-Apr-05 , Berlin, Germany
Blood glucose monitoring in patients with Type-2-diabetes: insights of new studies
05-Sep-04 , On the occasion of the Annual Meeting of the EASD, Munich, Germany
Diabetes and CVD - getting behind traditional risk targets
05-Sep-04 , On the occasion of the Annual Meeting of the EASD,Munich, Germany
Autonomic neuropathy of the diabetic foot: recent clinical findings and outlook
05-Sep-04 , On the occasion of the Annual Meeting of the EASD,Munich, Germany
Pendra®- Non-invasive continuous glucose monitoring based on impedance spectroscopy
05-Sep-04 , On the occasion of the Annual Meeting of the EASD,Munich, Germany
The path forward: Innovation in diabetes care
05-Sep-04 , On the occasion of the Annual Meeting of the EASD,Munich, Germany
Navigating the future of continuous glucose monitoring
04-Sep-04 , On the occasion of the Annual Meeting of the EASD,Munich, Germany